A phase II study of induction PD-1 blockade (nivolumab) in patients with surgically completely resectable mismatch repair deficient endometrial cancer (NIVEC)

Authors

Jeong‐Yeol Park (ORCID: https://orcid.org/0000-0003-2475-7123)
Myong Cheol Lim (ORCID: https://orcid.org/0000-0001-8964-7158)
Yoo-Young Lee (ORCID: https://orcid.org/0000-0001-5902-9877)
Hyun-Woong Cho (ORCID: https://orcid.org/0000-0002-7114-6301)
Jung‐Yun Lee (ORCID: https://orcid.org/0000-0001-7948-1350)
Yong Jae Lee (ORCID: https://orcid.org/0000-0003-0297-3116)
Jong‐Min Lee (ORCID: https://orcid.org/0000-0002-0562-5443)
Mi‐Kyung Kim (ORCID: https://orcid.org/0000-0001-6829-332X)

Institutions

Ulsan College (KR)
Ewha Womans University (KR)
Yonsei University (KR)
Korea University (KR)
Asan Medical Center (KR)
Samsung Medical Center (KR)
University of Ulsan (KR)
National Cancer Center (KR)
Kyung Hee University Hospital at Gangdong (KR)
Sungkyunkwan University (KR)

Publication Details

Journal: Journal of Gynecologic Oncology
Published: 2024-11-05
DOI: https://doi.org/10.3802/jgo.2025.36.e35
Citations: 4
Primary Topic: Genetic factors in colorectal cancer
Type: article
Field-Weighted Citation Impact: 1.70

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

A phase II study of induction PD-1 blockade (nivolumab) in patients with surgically completely resectable mismatch repair deficient endometrial cancer (NIVEC)

Jeong‐Yeol Park, Myong Cheol Lim, Yoo-Young Lee, Hyun-Woong Cho et al.

Nov 5, 2024

4 citations

Journal of Gynecologic Oncology

Genetic factors in colorectal cancer

1.70

article

A phase II study of induction PD-1 blockade (nivolumab) in patients with surgically completely resectable mismatch repair deficient endometrial cancer (NIVEC)

Jeong‐Yeol Park, Myong Cheol Lim, Yoo-Young Lee, Hyun-Woong Cho, Jung‐Yun Lee, Yong Jae Lee, Jong‐Min Lee, Mi‐Kyung Kim

November 5, 2024article en

4 citations

Abstract

No abstract available for this paper.

Journal of Gynecologic OncologyVol. 36(3)

Ulsan College (KR), Ewha Womans University (KR), Yonsei University (KR), Korea University (KR), Asan Medical Center (KR), Samsung Medical Center (KR), University of Ulsan (KR), National Cancer Center (KR), Kyung Hee University Hospital at Gangdong (KR), Sungkyunkwan University (KR)

Zero hunger

Openalex Percentile: Top 15%

Genetic factors in colorectal cancer

1.70

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A phase II study of induction PD-1 blockade (nivolumab) in patients with surgically completely resectable mismatch repair deficient endometrial cancer (NIVEC) — Jeong‐Yeol Park, Myong Cheol Lim, et al. · Journal of Gynecologic Oncology (2024) | TGRS Research Map | TGRS